Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 92, Issue 4, 2007, Pages

  Todd, D A ^a   Wright, A ^b   Smith, J ^b  

^a CANBERRA HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; DISEASE SEVERITY; FETUS; GEOGRAPHIC DISTRIBUTION; GESTATIONAL AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROLENTAL FIBROPLASIA; STATISTICAL SIGNIFICANCE;

AUSTRALIAN CAPITAL TERRITORY; BIRTH WEIGHT; EPIDEMIOLOGIC METHODS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETINOPATHY OF PREMATURITY; SEVERITY OF ILLNESS INDEX;

EID: 34347328225     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.096479     Document Type: Article

References (27)

1. Todd DA, Kennedy J, Cassell G, et al. Retinopathy of prematurity in infants <29 weeks' gestation at birth in New South Wales from 1986-92. J Paediatr Child Health 1998;34:32-6.
2. Todd DA, Cassell G, Kennedy J, et al. Retinopathy of prematurity in infants <32 weeks' gestation in New South Wales in 1993 and 1994. J Paediatr Child Health 1999;35:355-7.
3. Public Health Division. New South Wales Mothers and Babies 2000: New South Wales, Health Bulletin Supplement. 2001;12(S-3):66.
4. Ng YK, Fielder AR, Levene MI. Retinopathy of prematurity in the United Kingdom. Eye 1987;1:386-90.
5. Phelps DL. Retinopathy of prematurity: history, classification, and pathophysiology. NeoReviews 2001;2:e153-66.
6. Tin W, Milligan DW, Pennefather P, et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001;84:F106-10.
7. Chiang MF, Arons RR, Flynn JT, et al. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York State patient database. Ophthalmology 2004;111:1317-25.
8. Costeloe K, Hennessy E, Gibson AT, for the EPICure Study Group, et al. The EPICure Study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-71.
9. Dariow B, Hutchinson JL, Henderson-Smart DJ, et al. on behalf of the Australian and New Zealand Neonatal Network. Prenatal risk factors for significant retinopathy of prematurity in very preterm infants of the Australian and New Zealand Neonatal Network (ANZNN). Pediatrics 2005;115:990-6.
10. Cryotherapy for retinopathy of prematurity cooperative group. 15-Year outcomes following threshold retinopathy of prematurity. Final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005;123:311-8.
11. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-96.
12. The STOP-ROP multicenter study group. Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes, Pediatrics 2000;105:295- 310.
13. Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics 2004;113:394-6.
14. Haines L, Fielder AR, Baker H, et al. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed 2005;90:F240-4.
15. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasias. Pediatrics 1984;73:82-96.
16. Saito Y, Omoto T, Hatsukawa Y, et al. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graef's Arch Clin Exp Ophthalmol 1993;231:151-6.
17. Cunningham S, Fleck BW, Elton RA, et al. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995;346:1464- 5.
18. Chan-Ling T, Stone J. Retinopathy of prematurity: origins in the architecture of the retina. Prog Retinal Research 1993;12:155-78.
19. Chan-Ling T, Gock B, Stone J. The effect of oxygen on the vasoformative cell division. Evidence that "physiological hypoxia" is the stimulus for normal retinal vasculogenesis. Investigative Ophthalmol Visual Sci 1995;36:1201-14.
20. Beeby P, Chan D. Henderson-Smart D. Improved outcomes following the introduction of surfactant to an Australian neonatal unit. J Paediatr Child Health 1996;32:257-60.
21. Crowther CA, Haslam R, Hiller JE, et al. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913-9.
22. Kennedy J, Todd DA, Watts J, et al. Retinopathy of prematurity in infants <29 weeks' gestation: 3.5 years pre and post surfactant. J Ped Ophthalmol Strabismus 1997;34:289-92.
23. Committee for the classification of retinopathy of prematurity. An international classification of retinopathy of prematurity. Arch Ophtalmol 1984;102:1130-4.
24. ICROP Committee for the classification of the late stages of ROP. An international classification of retinopathy of prematurity, II: the classification of retinal detachment. Arch Ophtalmol 1987;105:906- 12.
25. An international committee for the classification of retinopathy of prematurity. The international classification of retinopathy of prematurity. Arch Ophthalmol 2005;123:991-9.
26. Hegerty JE, August P, Elder J, et al. The eye deceives me - an increase in the prevalence of retinopathy of prematurity in infants <28 weeks' gestational age in recent years [abstract]. Perinatal Society of Australia and New Zealand Annual Meeting, Adelaide, 2005, Abstract No A4.
27. Centre for Epidemiology and Research, NSW Department of Health and NSW & ACT. Midwives Data Collection, 1992-2002.